Canada Markets open in 4 hrs 35 mins

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.18-1.87 (-6.91%)
At close: 4:00PM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 5N/A
Enterprise Value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.06
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 353.69
52 Week Low 315.19
50-Day Moving Average 326.06
200-Day Moving Average 329.51

Share Statistics

Avg Vol (3 month) 31.87M
Avg Vol (10 day) 32.24M
Shares Outstanding 5198.35M
Implied Shares Outstanding 6N/A
Float 8196.83M
% Held by Insiders 16.73%
% Held by Institutions 191.04%
Shares Short (Sep. 14, 2021) 412.99M
Short Ratio (Sep. 14, 2021) 48.16
Short % of Float (Sep. 14, 2021) 48.44%
Short % of Shares Outstanding (Sep. 14, 2021) 46.53%
Shares Short (prior month Aug. 12, 2021) 411.66M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021

Profitability

Profit Margin -72.96%
Operating Margin (ttm)-112.86%

Management Effectiveness

Return on Assets (ttm)-10.23%
Return on Equity (ttm)-51.53%

Income Statement

Revenue (ttm)105.83M
Revenue Per Share (ttm)0.57
Quarterly Revenue Growth (yoy)79.20%
Gross Profit (ttm)32.57M
EBITDA -113.06M
Net Income Avi to Common (ttm)-77.21M
Diluted EPS (ttm)-0.34
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.14B
Total Cash Per Share (mrq)5.75
Total Debt (mrq)935.84M
Total Debt/Equity (mrq)362.38
Current Ratio (mrq)26.17
Book Value Per Share (mrq)1.44

Cash Flow Statement

Operating Cash Flow (ttm)-70.89M
Levered Free Cash Flow (ttm)-134.42M